Pasithea Therapeutics Corp (KTTA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $17.44M
Last updated: Nov 17, 2026 at 11:02 AM ET
Pasithea Therapeutics Corp (KTTA) Competitors
The companies most similar to Pasithea Therapeutics are Pelthos Therapeutics (PTHS), Plus Therapeutics (PSTV) and Phio Pharmaceuticals (PHIO). By market cap, Pasithea Therapeutics ranks 7th of the 13 companies on this page; Briacell Therapeutics (BCTX) is the largest at $29.60M.
Peer Comparison
KTTA's revenue growth of 1498.0% is above the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Pasithea Therapeutics (KTTA) | $17.44M | N/A | N/A | 0.0% | N/A | 1498.0% | 0.00% |
| Pelthos Therapeutics Inc. (PTHS) | $29.24M | N/A | 0.5x | -199.5% | -95.4% | 0.0% | 0.00% |
| Plus Therapeutics Inc (PSTV) | $26.64M | N/A | 2.0x | -230.2% | -827.8% | -2.9% | 0.00% |
| Phio Pharmaceuticals Corp (PHIO) | $9.21M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Marker Therapeutics Inc (MRKR) | $14.51M | N/A | 14.5x | -245.5% | N/A | -51.0% | 0.00% |
| Passage Bio Inc (PASG) | $13.68M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Transcode Therapeutics Inc (RNAZ) | $22.35M | N/A | N/A | 0.0% | -412.7% | 0.0% | 0.00% |
| Estrella Immunopharma Inc. (ESLA) | $22.36M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Psyence Biomedical Ltd. Common Shares (PBM) | $12.00M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Immutep Ltd ADR (IMMP) | $25.64M | N/A | 2.2x | 0.0% | N/A | 633.0% | 0.00% |
| Briacell Therapeutics Corp (BCTX) | $29.60M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Collplant Biotechnologies Ltd (CLGN) | $14.27M | N/A | 21.0x | 0.0% | N/A | -39.7% | 0.00% |
| Citius Pharmaceuticals Inc (CTXR) | $14.69M | N/A | 1.9x | 0.0% | -84.3% | 0.0% | 0.00% |
| Peer median | $18.52M | N/A | 2.1x | 0.0% | -254.1% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Pasithea Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. | PTHS competitors |
| Plus Therapeutics Inc (PSTV) | Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing... | PSTV competitors |
| Phio Pharmaceuticals Corp (PHIO) | Phio Pharmaceuticals Corp. The company is headquartered in Marlborough, Massachusetts. | PHIO competitors |
| Marker Therapeutics Inc (MRKR) | Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the development and commercialization of various T-cell-based... | MRKR competitors |
| Passage Bio Inc (PASG) | Passage Bio, Inc., a genetic drug company, develops transformative therapies for rare monogenic central nervous system (CNS) diseases. | PASG competitors |
| Transcode Therapeutics Inc (RNAZ) | TransCode Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development and commercialization of drugs for the treatment of metastatic... | RNAZ competitors |
| Estrella Immunopharma Inc. (ESLA) | Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. | ESLA competitors |
| Psyence Biomedical Ltd. Common Shares (PBM) | Psyence Biomedical Ltd. (PBM) is an innovative biotechnology company focused on harnessing the therapeutic potential of psychedelic compounds to address mental... | |
| Immutep Ltd ADR (IMMP) | Immutep Limited, a biotechnology company, is dedicated to the research and development of pharmaceutical candidates. | |
| Briacell Therapeutics Corp (BCTX) | BriaCell Therapeutics Corp. The company is headquartered in West Vancouver, Canada. | BCTX competitors |
| Collplant Biotechnologies Ltd (CLGN) | CollPlant Biotechnologies Ltd., an aesthetic and regenerative medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs... | CLGN competitors |
| Citius Pharmaceuticals Inc (CTXR) | Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets critical care products. | CTXR competitors |
Frequently Asked Questions About KTTA
Who are Pasithea Therapeutics' main competitors?
The companies most similar to Pasithea Therapeutics include Pelthos Therapeutics (PTHS), Plus Therapeutics (PSTV), Phio Pharmaceuticals (PHIO), Marker Therapeutics (MRKR) and Passage Bio (PASG), listed from the closest match.
Who is Pasithea Therapeutics' biggest competitor?
Briacell Therapeutics (BCTX) is the largest of the similar companies at $29.60M; Pelthos Therapeutics (PTHS) is the closest match by business profile, size, sector and industry.
How does KTTA stock compare with its competitors?
KTTA's net margin is 0.0% against a peer median of 0.0%.
Which of Pasithea Therapeutics' competitors pays a higher dividend?
Pasithea Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Pasithea Therapeutics bigger than its competitors?
No. Pasithea Therapeutics is 7th by market cap among the 13 companies on this page; the largest is Briacell Therapeutics (BCTX) at $29.60M.
KTTA pages: Overview, Earnings, Forecast, Financials, Competitors